Skin homeostasis relies on epidermal stem cells (ESC) that are mobilized from their niche located in the basal layer of the interfollicular epithelium (IFE) and the bulge of hair follicles (HF) to fuel highly proliferative transit amplifying compartments (TAC). Differentiation programs then generate the spinous, granular and cornified layers of the IFE or the different lineages of the mature HF.
1 ESC maintenance is orchestrated by a complex signalling network that remains incompletely characterized, including p63-, BMP-, TGFb-, Wnt/b-catenin-, Rac1-and Notch-initiated signalling cascades. 1 A recent work by Lacroix, Caramel et al. reveals that E4F1 and the Bmi1-Ink4a/ Arfp53 axis define a novel layer of regulation controlling ESC-dependent skin homeostasis (Fig. 1) .
2
E4F1 is an ubiquitously expressed multifunctional protein, originally identified as a transcription factor targeted by the adenoviral oncoprotein E1A. E4F1 also acts as an atypical ubiquitin E3-ligase for p53, 3 and interacts with several components of the p53 pathway, including p14 ARF and the polycomb member Bmi1. 4 We recently generated E4F1 conditional knock-out (KO) mice to circumvent the early embryonic developmental failure of E4F1 KO embryos 5 and address E4F1 functions in adult tissues. E4F1 inactivation in adult skin first induces a transient hyperplasia of the epidermis associated with increased proliferation of keratinocytes with basal/TAC properties, followed by severe ulcerative lesions, broad disorganisation of the IFE, massive hyperkeratosis and ultimately, a permanent loss E4F1 connects the Bmi1-ARF-p53 pathway to epidermal stem cell-dependent skin homeostasis 2 These results reveal a new regulatory network involved in ESC maintenance and proper skin homeostasis, implicating E4F1, Bmi1, the Ink4a/Arf locus and p53.
However, several questions remain unanswered. For instance, why are skin defects only developing after birth, although Cre-mediated recombination of E4F1 occurs much earlier during embryonic development? Among many possible scenari, Bmi1 and its downstream effectors might impact on ESC maintenance only at post-natal stages, as already suggested for hematopoietic stem cells (HSC). Interestingly, E4F1 has been previously shown to interfere with this HSC program. 4 However, in this case, the shRNA-mediated depletion of E4F1 rescues Bmi1 KO HSC exhaustion, 4 suggesting that the role of the E4F1-Bmi1 axis in stem cells maintenance differs from one tissue to another. Moreover, while the E4F1-Bmi1 genetic interaction identified in HSC was claimed to be independent of p53, 4 we found that p53 is clearly involved in E4F1 KO ESC phenotypes. The later observation raises queries about the exact function of the E4F1-Bmi1-Ink4a/Arfp53 network in stem cells homeostasis. In ESC, this pathway might play its usual "gate-keeper" function in response to genotoxic or developmental stresses, but it might also directly regulate normal programs of ESC self-renewal, as suggested in mammary gland progenitors 10 where p53 impacts on asymmetric cell divisions.
Finally, given the multiple roles of E4F1, it will be necessary to evaluate the relative importance of E4F1-associated transcriptional and E3-ligase activities in ESC functions. Ongoing studies should clarify these points. E4F1 inactivation in the entire skin or in the basal compartment of the epidermis induces skin homeostasis defects that result from cell autonomous alterations in ESC maintenance.
2 these ESC defects are partially restored upon inactivation of the Bmi-arf-Mdm2-p53 pathway, several components (p53, Bmi1 and arf) of which have been described to physically and functionally interact with E4F1.
